PharmaShots | Incisive News in 3 Shots

Subscribe Now

P-IIb Study

Eisai Presents Results of Lecanemab in P-IIb Study 201 Study for the Treatment of Alzheimer's Disease at CTAD 2021

Eisai Presents Results of Lecanemab in P-IIb Study 201 Study for the Treatment of Alzheimer's Disease at CTAD 2021

November 12, 2021

Novartis Reports Results of ligelizumab (QGE031) in P-IIb Study for the Treatment of Chronic Spontaneous Urticaria

Novartis Reports Results of ligelizumab (QGE031) in P-IIb Study for the Treatment of Chronic Spontaneous Urticaria

September 29, 2021

BridgeBio Presents Results of Encaleret in P-IIb Study for the Treatment of ADH1 at ENDO 2021

BridgeBio Presents Results of Encaleret in P-IIb Study for the Treatment of ADH1 at ENDO 2021

March 22, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us